[4] This means that any comparison of survodutides tolerability to another agent must account for how quickly each was titrated, not just the final dose
List of peptides being considered this week BPC-157 proposed for the treatment of ulcerative colitis KPV for wound healing and inflammatory conditions TB-500 for wound healing MOTS-C for obesity and osteoporosis Emideltide for opioid withdrawal, chronic insomnia, and narcolepsy Semax for certain neurological disorders Epitalon for insomnia The committee must determine whether to permit access through legally licensed state-compounding pharmacies Scott Brunner He added that since many of these experimental peptides do not have as large a clinical trial data base as FDA-approved drugs, evaluating them for the 503A Bulks List will be challenging
In Phase 2 studies, participants lost up to 1619% of body weight over 46 weeks, comparable to or greater than leading GLP-1 drugs
[DOI] [PubMed] [Google Scholar] 221.Wang L., Lu D., Wang X., Wang Z., Li W., Chen G
To date, only six substances have made it through the process to be put on the list, none of which are peptides and none of which are injectables
Dinkova A, Martinov D, Konova E
